Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
G1 Therapeutics, Inc. (GTHX) announced a webcast and conference call scheduled for May 3, 2023, at 8:30 a.m. ET, to provide a financial and corporate update for Q1 2023. The live event will discuss the company’s progress in developing COSELA® (trilaciclib), its first commercial product, and ongoing clinical trials across various solid tumors, including breast, lung, and bladder cancers. Participants are encouraged to register online to receive dial-in details, and a recorded version of the webcast will be available for 90 days post-event on the company's website. G1 Therapeutics continues to focus on advancing therapies that enhance patient outcomes in oncology.